BioSpace News Archive

Business

Cerus Corporation to Release Second Quarter 2021 Financial Results on August 3, 2021

Cerus Corporation (Nasdaq: CERS) announced today that its second quarter 2021 financial results will be released on Tuesday, August 3, 2021, after the close of the stock market.

July 20, 2021
·
1 min read
Business

Varex Schedules Third Quarter Fiscal Year 2021 Earnings Release and Conference Call

Varex Imaging Corporation (Nasdaq: VREX) today announced that it will report unaudited financial results for the third quarter of fiscal year 2021 following the close of regular trading on Tuesday, August 3, 2021.

July 20, 2021
·
1 min read
Lone Star Bio

Genprex to Participate in a Monthly CEO Roadshow Webinar Series

Series to highlight Genprex’s novel gene therapy pipeline in cancer and diabetes

July 20, 2021
·
5 min read
Biotech Bay

Agilent Announces Optimized and Verified Method for Testing Over 100 PFAS Compounds

Agilent Technologies Inc. (NYSE: A) today announced the availability of an optimized and verified eMethod for PFAS Analysis in Water by LC/TQ for testing per- and polyfluoroalkyl substances (PFAS) in drinking and surface water using liquid chromatography and mass spectrometry.

July 20, 2021
·
2 min read
Business

Thomas Scientific Lands Agilent as Distribution Partner

The nation’s largest pure-play distributor of scientific products continues their strong growth through agreement with industry leader

July 20, 2021
·
2 min read
Business

Neogen Reports Record Revenues for Fiscal 2021

Neogen Corporation (NASDAQ: NEOG) announced today the results for its fourth quarter and full 2021 fiscal year, which ended May 31, 2021.

July 20, 2021
·
9 min read
Genetown

Infinity Pharmaceuticals Hosting Webinar on MARIO-3 and MARIO-275 Phase 2 Trials

– MARIO-3 Phase 2 study evaluating eganelisib added to standard of care Tecentriq ® and Abraxane ® regimen in frontline triple negative breast cancer (TNBC)–

July 20, 2021
·
4 min read
Business

Rapid Dose Therapeutics and McMaster University Enter Next Stage of COVID-19 QuickStrip™ Vaccine Research Ahead of Schedule

Rapid Dose Therapeutics Corp. and McMaster University are pleased to provide the following update regarding the collaborative research into an orally delivered vaccine candidate for COVID-19, following the announcement made on June 23, 2021.

July 20, 2021
·
5 min read
Drug Development

KeifeRx Receives FDA Acceptance of Investigational New Drug for Phase 3 Study of Nilotinib BE in Early Alzheimer’s Disease

KeifeRx, LLC announced today that the company received an acceptance of its Investigational New Drug (IND) application from the United States Food and Drug Administration (FDA) to launch a Phase 3 trial named NILEAD for Nilotinib BE.

July 20, 2021
·
2 min read
Biotech Beach

Johnson & Johnson Vision Presents Scientific Data Validating Improved Surgical Outcomes With Latest Cataract Innovations And Legacy MGD Treatment At The 2021 ASCRS•ASOA Annual Meeting

New Evidence Evaluating the TECNIS Family of IOLs, including TECNIS Synergy and TECNIS Toric II, to be Presented in 10 Oral and 3 Poster Presentations

July 20, 2021
·
18 min read